Quest diagnostics prices $1.85 billion of senior notes

Secaucus, n.j. , aug. 15, 2024 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx) (the "company"), a leader in diagnostic information services, today announced the pricing of a public offering of $400 million aggregate principal amount of its 4.600% senior notes due 2027 (the "2027 notes"), $600 million aggregate principal amount of its 4.625% senior notes due 2029 (the "2029 notes") and $850 million aggregate principal amount of its 5.000% senior notes due 2034 (the "2034 notes," and together with the 2027 notes and the 2029 notes, the "notes") under quest diagnostics' shelf registration statement.
DGX Ratings Summary
Quant
DGX Quant Ranking
Sector
Industry
Quant Rating
Quant Score